Market Research Report
Global H1N1 Vaccines Market 2016-2020
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||254965|
|Published||Content info||83 Pages
Delivery time: 1-2 business days
|Global H1N1 Vaccines Market 2016-2020|
|Published: June 3, 2016||Content info: 83 Pages||
The high level of maturity in the H1N1 vaccines market has renewed the push to develop quadrivalent vaccines that address areas of the market with unmet medical needs. Vaccines that prevent H1N1 have been a long-standing void in the treatment algorithm. Therefore, the introduction advanced vaccines in the next decade will likely alter the global H1N1 vaccines market landscape. Sanofi, AstraZeneca, and VaxInnate have also invested in quadrivalent vaccines, such as Sanofi's VaxiGrip, VaxInnate's VAX2012Q, and AstraZeneca's MEDI-550 vaccine, which will impact the US and Europe markets during the forecast period. Other areas of opportunity for novel entrants include vaccines with improved immune response and immunogenic infant vaccines.
Technavio's analysts forecast the global H1N1 vaccines market to grow at a CAGR of 4.17% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global H1N1 vaccines market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of vaccines used to prevent H1N1 infection. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period.
The market is divided into the following segments based on geography:
Technavio's report, Global H1N1 Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.